REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHAug 13

   Ownership stake disclosure by BARCLAYS PLC (amended)

   BARCLAYS PLC, filed by

2. NOTABLE10-QREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHAug 12

   Quarterly report

3. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHAug 12

   Current report

4. ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHAug 3

   Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)

   INTEGRATED CORE STRATEGIES (US) LLC, filed by

5. ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHJul 31

   Ownership stake disclosure by UBS Group AG (amended)

   UBS Group AG, filed by

6. NOTABLE25-NSEREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHJul 10

   Delisting notice

   Nasdaq Stock Market LLC, filed by

7. ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMay 15

   Ownership stake disclosure by CVI Investments, Inc. (amended)

   CVI Investments, Inc., filed by

8. ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMay 14

   Ownership stake disclosure by BARCLAYS PLC

   BARCLAYS PLC, filed by

9. NOTABLE10-QREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMay 13

   Quarterly report

10. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMay 13

    Current report

11. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMay 13

    Current report

12. ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMay 7

    Ownership stake disclosure by UBS Group AG

    UBS Group AG, filed by

13. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHApr 15

    Current report

14. ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 30

    Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC

    INTEGRATED CORE STRATEGIES (US) LLC, filed by

15. ROUTINES-8REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 30

    Employee stock plan registration

16. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 30

    Current report

17. NOTABLE10-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 30

    Annual report

18. ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 25

    Ownership stake disclosure by CVI Investments, Inc.

    CVI Investments, Inc., filed by

19. NOTABLESCHEDULE 13D/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 24

    Ownership stake disclosure by Parag Saxena (amended)

    Parag Saxena, filed by

20. ROUTINE4REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 20

    2 insider filings

    Narayan Prabhu, insider filing for RVPH

    Show all 2

    • 4Insider filing for RVPHMar 20
    • 4Insider filing for RVPHMar 20

    Narayan Prabhu, reporting

21. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 19

    Current report

22. ROUTINE424B5REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 19

    Securities offering

23. ROUTINE424B5REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 18

    Securities offering

24. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHMar 5

    Current report

25. ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHFeb 17

    Ownership stake disclosure by 683 Capital Management, LLC (amended)

    683 Capital Management, LLC, filed by

26. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHJan 23

    Current report

27. ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHJan 16

    Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)

    INTEGRATED CORE STRATEGIES (US) LLC, filed by

28. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHDec 23, 2025

    Current report

29. NOTABLESCHEDULE 13D/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHWDec 22, 2025

    Ownership stake disclosure by Parag Saxena (amended)

    Parag Saxena, filed by

30. ROUTINE4REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHDec 19, 2025

    4 insider filings

    Leslie D. Funtleyder, insider filing for RVPH

    Show all 4

    • 4Insider filing for RVPHDec 19, 2025
    • 4Insider filing for RVPHDec 19, 2025
    • 4Insider filing for RVPHDec 19, 2025
    • 4Insider filing for RVPHDec 19, 2025

    Leslie D. Funtleyder, reporting

31. NOTABLE25-NSEREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHDec 12, 2025

    Delisting notice

    Nasdaq Stock Market LLC, filed by

32. ROUTINEDEFA14AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHDec 5, 2025

    Additional proxy materials

33. ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHWNov 13, 2025

    REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) filed an 8-K reporting a leadership change, with the company's Chief Executive Officer stepping down.

34. NOTABLE10-QREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHWNov 13, 2025

    REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) filed its Q3 2025 10-Q report, providing investors with an update on the company's financial performance and operational status.

35. ROUTINEARSREVIVA PHARMACEUTICALS HOLDINGS, INC.Nov 4, 2025

    Annual report to shareholders

36. ROUTINEDEFA14AREVIVA PHARMACEUTICALS HOLDINGS, INC.Nov 4, 2025

    Additional proxy materials

37. ROUTINEDEF 14AREVIVA PHARMACEUTICALS HOLDINGS, INC.Nov 4, 2025

    Proxy statement

Older filings on EDGAR